A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on: January 08,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on:January 08,2024

Russia's Cancer Vaccine 'Enteromix': A Breakthrough Using mRNA Technology

Updated on: September 15,2025

Russia's Cancer Vaccine 'Enteromix': A Breakthrough Using mRNA Technology

Updated on:September 15,2025

Research suggests metabolite differences in young-onset versus average-onset colorectal cancer

byCleveland ClinicCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0New research from Cleveland Clinic supports the theory that environmental exposures—such as red

Updated on: January 22,2024

Research suggests metabolite differences in young-onset versus average-onset colorectal cancer

byCleveland ClinicCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0New research from Cleveland Clinic supports the theory that environmental exposures—such as red

Updated on:January 22,2024

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on: March 22,2024

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on:March 22,2024

Photodynamic therapy offers promise for cancer treatment

by Marcia Kaye,University of Toronto MississaugaHuman colorectal cancer cells. Credit: National Cancer Institute/UnsplashWhile chemotherapy drugs can be lifesaving, they don't work for all p

Updated on: December 23,2023

Photodynamic therapy offers promise for cancer treatment

by Marcia Kaye,University of Toronto MississaugaHuman colorectal cancer cells. Credit: National Cancer Institute/UnsplashWhile chemotherapy drugs can be lifesaving, they don't work for all p

Updated on:December 23,2023

Cancer cells adopt hitherto unknown state to facilitate metastasis

by Susann Huster,Leipzig UniversityCredit: Pixabay/CC0 Public DomainThe ancient Egyptians, as described in the Ebers Papyrus, already knew that palpation—feeling for hardened lumps—can help diag

Updated on: December 18,2023

Cancer cells adopt hitherto unknown state to facilitate metastasis

by Susann Huster,Leipzig UniversityCredit: Pixabay/CC0 Public DomainThe ancient Egyptians, as described in the Ebers Papyrus, already knew that palpation—feeling for hardened lumps—can help diag

Updated on:December 18,2023

Testosterone is an ally of macrophages in the battle against adrenal cancers

byCNRSMacrophages attacking adrenal tumor in male mouse. Credit: © Julie Olabe CNRS/GReDWhy are cancers of the adrenal glands more common among women? Why are prognoses worse for them? A team of

Updated on: December 22,2023

Testosterone is an ally of macrophages in the battle against adrenal cancers

byCNRSMacrophages attacking adrenal tumor in male mouse. Credit: © Julie Olabe CNRS/GReDWhy are cancers of the adrenal glands more common among women? Why are prognoses worse for them? A team of

Updated on:December 22,2023

Identifying new potential in cancer-killing T cells

by Kate Ledger,Mayo ClinicGraphical illustration of a general role of ME1 in resilient CD8+T cells. Credit:Science Advances(2023). DOI: 10.1126/sciadv.adi2414When Joanina Gicob

Updated on: January 25,2024

Identifying new potential in cancer-killing T cells

by Kate Ledger,Mayo ClinicGraphical illustration of a general role of ME1 in resilient CD8+T cells. Credit:Science Advances(2023). DOI: 10.1126/sciadv.adi2414When Joanina Gicob

Updated on:January 25,2024

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ

Updated on: December 18,2023

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ

Updated on:December 18,2023

New open-source software judges accuracy of computer predictions of cancer genetics

byThe Francis Crick InstituteCredit: CC0 Public DomainCancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly

Updated on: December 22,2023

New open-source software judges accuracy of computer predictions of cancer genetics

byThe Francis Crick InstituteCredit: CC0 Public DomainCancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly

Updated on:December 22,2023

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc

Updated on: January 04,2024

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc

Updated on:January 04,2024

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Updated on: December 18,2023

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Updated on:December 18,2023